Viemed Healthcare: Maintaining 'Buy' Rating Post Q1 On Improving Capital Efficiency
Viemed Healthcare Inc VMD
$9.64
▲ +3.10%
(+$0.29)
Open
$9.21
Prev Close
$9.35
Day Range
$8.69 – $9.65
52W Range
$5.93 – $10.18
Market Cap
$353.08M
P/E (TTM)
24.82
Beta
1.15
EPS (TTM)
$0.37
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2017-12-22 |
| Shares Out. | 38,600,000 |
| Website | viemed.com/ ↗ |
| Phone | 13375043802 |
Viemed Healthcare Inc is a publicly traded company under the ticker symbol VMD on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
6 analysts (2026-05-01)
📰 Latest News for VMD
Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 1Q26
Viemed Healthcare, Inc. 2026 Q1 - Results - Earnings Call Presentation
Viemed Healthcare, Inc. (VMD) Q1 2026 Earnings Call Transcript
Transcript : Viemed Healthcare, Inc., Q1 2026 Earnings Call, May 06, 2026
Viemed Healthcare Q1 2026 Earnings Call: Complete Transcript
Viemed Healthcare (NASDAQ:VMD) Q1 2026 Earnings: Revenue Beat Offset by EPS Miss and Margin Pressure
Viemed Healthcare Raises FY2026 Sales Guidance from $310.000M-$320.000M to $312.000M-$320.000M vs $315.450M Est